Stay updated on Efficacy & Safety of M2951 in Relapsing MS Clinical Trial
Sign up to get notified when there's something new on the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page.

Latest updates to the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page
- CheckyesterdayChange DetectedThe Publications section was updated to state that publications are provided voluntarily by the study entrants and are automatically filled from PubMed, and the revision version changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoChange Detected- Notice about government funding and NIH/CC operating status has been removed from the page.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe update shows minor textual edits and a timestamp change, with no changes to core study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check51 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference1%

- Check59 days agoChange DetectedThe page has been updated to version v3.1.0 and several related topics (MedlinePlus topics on drug safety, counterfeit drugs, pharmaceutical preparations, and substandard drugs) have been removed.SummaryDifference0.2%

- Check73 days agoChange DetectedUpdated the page to Revision: v3.0.2 (replacing v3.0.1); the 'Back to Top' link was removed.SummaryDifference0.1%

Stay in the know with updates to Efficacy & Safety of M2951 in Relapsing MS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page.